This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Stemcell Technologies Inc., a Canadian-owned, for-profit biotechnology company. The contract, valued at $11,733.00, is for the supply of a STEMCELL ROBOSEP PMI, a specialized cell separation system, to support biomedical research at the VA facility located in Los Angeles, California. The contract has an ultimate completion date of March 31, 2026 and was awarded on April 1, 2025.
Stemcell Technologies Inc. is a key supplier of biological materials, laboratory supplies, and scientific equipment to various federal research institutions, including the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Food and Drug Administration (FDA), as well as the Department of Veterans Affairs. The company holds a significant $10,000,000 Blanket Purchase Agreement (BPA) with the NIH Office of Logistics and Acquisition Operations, which facilitates the efficient procurement of critical biomedical research supplies for multiple NIH institutes and centers. This contract award is not designated as a small business set-aside.
Generated 3/28/25, 10:58 AM